Elferink BG - Search Results

1

Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.

Feitsma AL, van der Voort EI, Franken KL, el Bannoudi H, Elferink BG, Drijfhout JW, Huizinga TW, de Vries RR, Toes RE, Ioan-Facsinay A. Feitsma AL, et al. Among authors: elferink bg. Arthritis Rheum. 2010 Jan;62(1):117-25. doi: 10.1002/art.25059. Arthritis Rheum. 2010. PMID: 20039411 Free article.

2

Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW, Ottenhoff TH, Toes RE. Morgan ME, et al. Among authors: elferink bg. Hum Immunol. 2005 Jan;66(1):13-20. doi: 10.1016/j.humimm.2004.05.016. Hum Immunol. 2005. PMID: 15620457

3

Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.

van Laar JM, Miltenburg AM, Verdonk MJ, Leow A, Elferink BG, Daha MR, Cohen IR, de Vries RR, Breedveld FC. van Laar JM, et al. Among authors: elferink bg. J Autoimmun. 1993 Apr;6(2):159-67. doi: 10.1006/jaut.1993.1013. J Autoimmun. 1993. PMID: 8098938 Clinical Trial.

4

Activated synovial T cell clones from a patient with rheumatoid arthritis induce proliferation of autologous peripheral blood-derived T cells.

van Laar JM, Miltenburg AM, Verdonk MJ, Leow A, Elferink BG, Daha MR, de Vries RR, Breedveld FC. van Laar JM, et al. Among authors: elferink bg. Cell Immunol. 1993 Jan;146(1):71-9. doi: 10.1006/cimm.1993.1007. Cell Immunol. 1993. PMID: 8425232

5

The biologic importance of conserved major histocompatibility complex class II motifs in primates.

Elferink BG, Geluk A, Otting N, Slierendregt BL, van Meijgaarden KE, de Vries RR, Ottenhoff TH, Bontrop RE. Elferink BG, et al. Hum Immunol. 1993 Nov;38(3):201-5. doi: 10.1016/0198-8859(93)90541-8. Hum Immunol. 1993. PMID: 8106278

6

Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells.

Elferink BG, Ottenhoff TH, de Vries RR. Elferink BG, et al. Scand J Immunol. 1985 Nov;22(5):585-9. doi: 10.1111/j.1365-3083.1985.tb01918.x. Scand J Immunol. 1985. PMID: 3001928

7

Role of HLA class II products in proliferative T-lymphocyte responses to PPD. Evidence of a regulatory influence associated with MB1.

van Eden W, Elferink BG, Hermans J, de Vries RR, van Rood JJ. van Eden W, et al. Among authors: elferink bg. Scand J Immunol. 1984 Dec;20(6):503-10. doi: 10.1111/j.1365-3083.1984.tb01032.x. Scand J Immunol. 1984. PMID: 6083600

8

Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.

van Eden W, Elferink BG, de Vries RR, Leiker DL, van Rood JJ. van Eden W, et al. Among authors: elferink bg. Clin Exp Immunol. 1984 Jan;55(1):140-8. Clin Exp Immunol. 1984. PMID: 6362932 Free PMC article.

9

HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.

Haanen JB, Ottenhoff TH, Voordouw A, Elferink BG, Klatser PR, Spits H, De Vries RR. Haanen JB, et al. Among authors: elferink bg. Scand J Immunol. 1986 Jan;23(1):101-8. doi: 10.1111/j.1365-3083.1986.tb01947.x. Scand J Immunol. 1986. PMID: 2422737

10

T-cell vaccination in patients with nickel allergic contact dermatitis.

Dolhain RJ, Elferink BG, Leow A, Witvliet MD, Claas FH, Struyk L, Vermeer BJ, Breedveld FC, De Vries RR. Dolhain RJ, et al. Among authors: elferink bg. J Invest Dermatol. 1995 Jul;105(1):143-4. doi: 10.1111/1523-1747.ep12313516. J Invest Dermatol. 1995. PMID: 7615969 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page